May 4, 2023
Start at 9:00 Kyiv time
Language: English and Ukrainian (real-time translation provided)
International Conference
Psychedelic assisted therapy in the treatment of post-traumatic conditions
International Experience and Prospects for Implementation in Ukraine
Leading foreign experts will share insights on the international practice of psychedelic-assisted therapy (PAT), the latest scientific research findings, and the legislative regulation of PAT around the world. Ukrainian experts will address domestic challenges within mental health services. Additionally, military veterans from both Ukraine and abroad will share their personal experiences with PAT.
Organizers
Center for mental health and rehabilitation of veterans "Forest Glade" of the Ministry of Health of Ukraine
Nonprofit organization "Ukrainian Psychedelic Research Association"
More about the speakers
This conference is intended for mental health professionals, such as psychologists, psychiatrists, and psychotherapists, as well as veterans, military personnel, state management experts, and policymakers who shape decisions in the field of mental healthcare.
Opening
Dr. Rick Doblin
Founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit organization based in the United States. Since its establishment in 1986, MAPS has been dedicated to raising awareness and promoting education on the therapeutic potential of psychedelics.
Dr. Robin Carhart-Harris
Psychologist and neurobiologist who currently serves as a professor and head of the Center for Psychedelic Research at the Faculty of Medicine, Imperial College London. He led the first clinical trial of psilocybin in the UK and has conducted extensive research on the effects of psilocybin and MDMA using MRI and MEG brain scans under the guidance of Professor David Nutt.
Amanda Feilding
Founder of the Beckley Foundation (UK) and the "Queen of Consciousness" according to New Scientist magazine. She was the one who initiated groundbreaking research projects on the use of psilocybin to overcome depression and nicotine addiction, brain imaging studies and the effects of psilocybin and MDMA on cerebral blood supply, etc.
Mary Cosimano
Director of the Facilitation Department at the Johns Hopkins Center for Psychedelic and Consciousness Research. Specializes in research coordination, facilitator training, and conducting psychedelic sessions, having completed over 450 sessions.
Dr. Ingmar Gorman
Clinical psychologist and co-founder of Fluence, an educational company that trains mental health professionals in the fundamentals of psychedelic-assisted therapy.
Anne St Goar, MD
Primary care physician at HVMA and board-certified psychedelic therapist emeritus, who is a member of the Boston Psychedelic Research Group.
Dr. Ben Sessa
Оne of the world's leading psychedelic researchers, specialising in the psychotherapeutic effects of medical cannabis, MDMA and psilocybin.
Dr. Henrik Jungaberle
A Swiss psychotherapist and author of the book "Therapy with substance"
Friederike Meckel Fischer
A Swiss psychotherapist and author of the book "Therapy with substance"
Tania de Jong
Сo-founder and executive director of mental health charity Mind Medicine Australia
International experts
Dr. David Nutt
Professor of Neuropsychopharmacology and the Director of the Neuropsychopharmacology Laboratory at the Department of Brain Sciences at Imperial College London. He has also held prominent positions as the chairman of the Committee on the Misuse of Drugs, the Committee on Safety of Medicines, the National Health Service Drugs Committee, and the Ministry of Defense Research Council.
Dr. Eric Vermetten
Psychiatrist serving as a strategic research advisor for veterans at the Military Mental Health Service of the Ministry of Defense of the Netherlands and the National Trauma Center ARQ.
Dr. Keren Tzarfaty
Clinical director of the Open Access project, a joint initiative by MAPS and the Ministry of Health of Israel.
Marcus and Amber Capone
Founders of Veterans Exploring Treatment Solutions (VETS), a US-based nonprofit organization dedicated to providing resources, research, and advocacy for Special Operations veterans seeking psychedelic treatment.
Dr. Olga Chernoloz
Dr Chernoloz is a specialist in neuropsycho-pharmacology with a PhD in neuroscience from the University of Ottawa.
Ukrainian experts
Kseniia Vosnitsyna
Director of the State Institution "Forest Glade" Center for Psychological Health and Rehabilitation of Veterans, under the Ministry of Health of Ukraine.
Vladislav Matrenitsky
Psychotherapist, founder of the Expio Center for Psychotherapy, Psychosomatics, and Psychedelic Medicine Expio.
Oleh Chaban
Psychiatrist and Head of the Department of Medical Psychology, Psychosomatic Medicine, and Psychotherapy at the Medical and Psychological Faculty of the Bogomolets National Medical University.
Victor Dosenko
Pathophysiologist and geneticist, currently serving as the head of the Department of General and Molecular Pathophysiology at the O.O. Bogomolets Institute of Physiology, part of the National Academy of Sciences of Ukraine.
Panel discussion participants
Jonathan Lubecky
US Army veteran who participated in clinical trials of MDMA therapy for PTSD.
Stanislav Gibadulin
An Armed Forces special forces member with the call sign "Hitman" successfully overcame PTSD with the help of PAT.
Jesse Gould
Jesse Gould is Founder and President of the Heroic Hearts Project, nonprofit pioneering psychedelic therapies for military veterans.
Олексій Скіртач
Military psychologist.
We thank our partners for support
American non-profit organization that supports Ukrainian war victims.
American non-profit organization that aims to help Ukrainian adults and children heal from the trauma caused by the war.
Ukrainian non-profit organization that implements innovative ideas, technologies, knowledge, and practices to improve the quality of life for military and civilian people in need of assistance in overcoming mental trauma caused by war.